|Bid||14.62 x 0|
|Ask||14.64 x 0|
|Day's Range||14.60 - 15.10|
|52 Week Range||13.43 - 27.00|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||N/A|
|Expense Ratio (net)||0.86%|
The Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) offers investors significant risk diversification. Here's why this ETF is set to generate substantial returns in 2019 and beyond.
EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) reports today that it has been added to The Cannabis ETF (NYSE:THCX) (“THCX”) which trades on the New York Stock Exchange. THCX follows the Innovation Labs Cannabis Index, which is a portfolio of 35 holdings expected to benefit from growth of the legal marijuana, CBD and hemp industries. EnWave currently has three royalty-bearing commercial license agreements with Canadian cannabis companies and one royalty-bearing commercial license agreement with a hemp producer in the United States.
Investing in cannabis can be very risky these days, and that's where the Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) might offer investors a bit more stability.
Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ) could be the best way for contrarian investors to bet on the long-term potential of the marijuana industry
Investing in an ETF is often a good way to hedge your bets and have a more stable return, one that's ...